replacing Jason Gorevic, who will also depart from the Board of Directors of the Company as required by his employment agreement.
Key facts
Extracted from this filing and checked against the source text.
Earnings ReleasesSEC 8-K Item 2.02confidence 0.9
Teladoc Health, Inc. updated its quarter ended March 31, 2024 guidance (reaffirmed).
Period
quarter ended March 31, 2024
Guidance
reaffirmed
Result
preliminary results
Exact text from the filing
On April 5, 2024, Teladoc Health, Inc. (“Teladoc Health” or the “Company”) announced that it continues to expect its outlook for the quarter ended March 31, 2024 and the year ending December 31, 2024 to be consistent with the outlook ranges disclosed in the Company’s earnings release on February 20, 2024. The financial results for the quarter ended March 31, 2024 are preliminary, unaudited and subject to change
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.